| BioVision |
1844-100 |
7-Amino-4-methylcoumarin
|
100 mg |
|
|
| BioVision |
1845-5 |
USP14 Inhibitor, IU1
|
5 mg |
|
|
| BioVision |
1844-25 |
7-Amino-4-methylcoumarin
|
25 mg |
|
|
| BioVision |
1846-1 |
PS-341
|
1 mg |
|
|
| BioVision |
1845-25 |
USP14 Inhibitor, IU1
|
25 mg |
|
|
| BioVision |
1842-1 |
Nutlin-3
|
1 mg |
|
|
| BioVision |
1842-5 |
Nutlin-3
|
5 mg |
|
|
| BioVision |
1843-50 |
Rosmarinic Acid
|
50 mg |
|
|
| BioVision |
1838-5 |
8-Br-cGMP
|
5 mg |
|
|
| BioVision |
1843-250 |
Rosmarinic Acid
|
250 mg |
|
|
| BioVision |
1841-50 |
(-)-Epigallocatechin gallate
|
50 mg |
|
|
| BioVision |
1840-500 |
Microcystin-LR
|
500 µg |
|
|
| BioVision |
1840-100 |
Microcystin-LR
|
100 µg |
|
|
| BioVision |
1838-25 |
8-Br-cGMP
|
25 mg |
|
|
| BioVision |
1837-25 |
8-Br-cAMP
|
25 mg |
|
|
| BioVision |
1837-5 |
8-Br-cAMP
|
5 mg |
|
|
| BioVision |
1835-25 |
Calpain Inhibitor II, ALLM
|
25 mg |
|
|
| BioVision |
1836-5 |
SU 1498
|
5 mg |
|
|
| BioVision |
1836-1 |
SU 1498
|
1 mg |
|
|
| BioVision |
1834-5 |
Calpain Inhibitor I, ALLN
|
5 mg |
|
|
| BioVision |
1835-5 |
Calpain Inhibitor II, ALLM
|
5 mg |
|
|
| BioVision |
1832-5 |
Proteasome Substrate, Fluorogenic
|
5 mg |
|
|
| BioVision |
1833-5 |
Suc-Leu-Leu-Val-Tyr-AMC
|
5 mg |
|
|
| BioVision |
1834-25 |
Calpain Inhibitor I, ALLN
|
25 mg |
|
|
| BioVision |
1832-1 |
Proteasome Substrate, Fluorogenic
|
1 mg |
|
|
| BioVision |
1833-25 |
Suc-Leu-Leu-Val-Tyr-AMC
|
25 mg |
|
|
| BioVision |
1830-500 |
Berberine Chloride
|
500 mg |
|
|
| BioVision |
1831-1 |
MG-115
|
1 mg |
|
|
| BioVision |
1829-250 |
Bafilomycin A1
|
250 µg |
|
|
| BioVision |
1831-5 |
MG-115
|
5 mg |
|
|
| BioVision |
1828-500 |
Amiodarone Hydrochloride
|
500 mg |
|
|
| BioVision |
1830-100 |
Berberine Chloride
|
100 mg |
|
|
| BioVision |
1829-50 |
Bafilomycin A1
|
50 µg |
|
|
| BioVision |
1825-500 |
Chloroquine Diphosphate
|
500 mg |
|
|
| BioVision |
1826-100 |
Niclosamide
|
100 mg |
|
|
| BioVision |
1828-100 |
Amiodarone Hydrochloride
|
100 mg |
|
|
| BioVision |
1823-25 |
Heparin-Binding Peptide III
|
25 mg |
|
|
| BioVision |
1824-5 |
Integrin Ligand peptide
|
5 mg |
|
|
| BioVision |
1824-25 |
Integrin Ligand peptide
|
25 mg |
|
|
| BioVision |
1827-10 |
Rottlerin
|
10 mg |
|
|
| BioVision |
1826-500 |
Niclosamide
|
500 mg |
|
|
| BioVision |
1821-25 |
Heparin-Binding Peptide I
|
25 mg |
|
|
| BioVision |
1822-5 |
Heparin-Binding Peptide II
|
5 mg |
|
|
| BioVision |
1822-25 |
Heparin-Binding Peptide II
|
25 mg |
|
|
| BioVision |
1825-100 |
Chloroquine Diphosphate
|
100 mg |
|
|
| BioVision |
1819-500 |
SH-6
|
500 µg |
|
|
| BioVision |
1823-5 |
Heparin-Binding Peptide III
|
5 mg |
|
|
| BioVision |
1821-5 |
Heparin-Binding Peptide I
|
5 mg |
|
|
| BioVision |
1820-100 |
Bongkrekic Acid, Triammonium Salt
|
100 µg |
|
|
| BioVision |
1816-25 |
Tranylcypromine Hemisulfate
|
25 mg |
|
|